tiprankstipranks
Trending News
More News >
Panbela Therapeutics (PBLA)
OTHER OTC:PBLA
US Market

Panbela Therapeutics (PBLA) Income Statement

Compare
245 Followers

Panbela Therapeutics Income Statement

Last quarter (Q3 2024), Panbela Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Panbela Therapeutics's net income was $-7.17M. See Panbela Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -25.65M$ -35.73M$ -10.01M$ -5.75M$ -4.32M
Operating Expenses
$ 25.65M$ 34.09M$ 10.01M$ 5.75M$ 4.32M
Depreciation and Amortization
$ -25.53M$ 16.36K$ 10.01K$ 0.00$ 4.32K
EBITDA
$ -51.29M$ -34.74M$ -10.61M$ -5.05M$ -4.42M
Operating Income
$ -51.29M$ -34.09M$ -10.01M$ -5.75M$ -4.32M
Other Income/Expenses
$ 25.84M$ -956.00K$ -613.00K$ 691.00K$ -2.29M
Pretax Income
$ -25.45M$ -35.05M$ -10.62M$ -5.06M$ -6.62M
Net Income
$ -25.26M$ -34.93M$ -10.13M$ -4.77M$ -6.20M
Per Share Metrics
Basic EPS
$ -232.43K$ -40.75K$ -20.77K$ -14.80K$ -26.10K
Diluted EPS
$ -232.43K$ -40.75K$ -20.77K$ -14.80K$ -26.10K
Weighted Average Shares Outstanding
-----
Weighted Average Shares Outstanding (Diluted)
-----
Currency in USD

Panbela Therapeutics Earnings and Revenue History